T0	Limitation 21823 21829	First,
T1	Limitation 22137 22144	Second,
T2	Limitation 22311 22319	Although
T3	Limitation 22550 22556	Third,
T4	Blinding 21841 21861	was not double-blind
T5	SampleSize 22145 22309	the number of patients enrolled in this study did not reach the sample size defined in advance to prove non-inferiority of TCZ switched from MTX to TCZ added to MTX
T6	UnderpoweredStudy 22526 22548	the insufficient power
T7	OutcomeMeasures 22431 22514	the superiority in the sensitivity analysis using the SDAI and the CDAI was limited
T8	Intervention 22557 22637	the dose of MTX used in this study was lower than that used in Western countries
